Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00590512 · ClinicalTrials.gov registry record · Early Phase 1

Dietary Salt Intake and Vascular Function

A Early Phase 1 study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
Early Phase 1
Development phase
133
Enrollment target

NCT00590512: Completed Early Phase 1 study, sponsored by Brigham and Women's Hospital.

NCT00590512 is a Early Phase 1 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 133 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (151% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00590512, a Early Phase 1 study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
Early Phase 1
Development phase
133 participants
Enrollment target

Study Summary

The purpose of this study is to look at the effects of high- and low-salt diets on blood vessel function in healthy subjects.

Interventions

  • DIETARY_SUPPLEMENT High sodium
  • DIETARY_SUPPLEMENT Low sodium

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2005-03
Est. Completion 2012-11
Phase Early Phase 1
Brigham and Women's Hospital

937 total trials

What the finished NCT00590512 record still lists

NCT00590512 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (151% higher).

The record links to 0 conditions, and to 2 interventions - of which High sodium is the first listed.

NCT00590512 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00590512 about?

NCT00590512 is a clinical study titled "Dietary Salt Intake and Vascular Function". The purpose of this study is to look at the effects of high- and low-salt diets on blood vessel function in healthy subjects.

What is the current status of trial NCT00590512?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 133 participants. The study started on 2005-03. Estimated completion is 2012-11.

What interventions are being tested in trial NCT00590512?

The interventions under investigation include: High sodium (DIETARY_SUPPLEMENT), Low sodium (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00590512?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00590512's enrollment target sits among peer trials

133 130th of 2000 higher than 1,871 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04276870 · 133 participants · Phase 2

    Orphan Indications for CD19 Redirected Autologous T Cells

  • NCT04671771 · 133 participants · NA

    A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • NCT05610085 · 133 participants · Phase 2

    A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

  • NCT06206486 · 133 participants

    The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00590512, the US trial registry maintained by the National Library of Medicine. NCT00590512 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.